Click for best price
Injectable Anthelmintic Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Injectable Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anthelmintic Drugs. This report contains market size and forecasts of Injectable Anthelmintic Drugs in global, including the following market information:
Global Injectable Anthelmintic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Injectable Anthelmintic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Benzimidazoles Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Injectable Anthelmintic Drugs include Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck and Boehringer Ingelheim International, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Injectable Anthelmintic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Anthelmintic Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Injectable Anthelmintic Drugs Market Segment Percentages, by Type, 2022 (%)
Benzimidazoles
Piperazine
Imidazothiazole
Spiroindoles
Others
Global Injectable Anthelmintic Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Injectable Anthelmintic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Others
Global Injectable Anthelmintic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Injectable Anthelmintic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Anthelmintic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Injectable Anthelmintic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Injectable Anthelmintic Drugs, market overview.
Chapter 2: Global Injectable Anthelmintic Drugs market size in revenue.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injectable Anthelmintic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Injectable Anthelmintic Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Injectable Anthelmintic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Anthelmintic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injectable Anthelmintic Drugs Overall Market Size
2.1 Global Injectable Anthelmintic Drugs Market Size: 2022 VS 2030
2.2 Global Injectable Anthelmintic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Injectable Anthelmintic Drugs Players in Global Market
3.2 Top Global Injectable Anthelmintic Drugs Companies Ranked by Revenue
3.3 Global Injectable Anthelmintic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Injectable Anthelmintic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Injectable Anthelmintic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Injectable Anthelmintic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Injectable Anthelmintic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Injectable Anthelmintic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Injectable Anthelmintic Drugs Market Size Markets, 2022 & 2030
4.1.2 Benzimidazoles
4.1.3 Piperazine
4.1.4 Imidazothiazole
4.1.5 Spiroindoles
4.1.6 Others
4.2 By Type - Global Injectable Anthelmintic Drugs Revenue & Forecasts
4.2.1 By Type - Global Injectable Anthelmintic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Injectable Anthelmintic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Injectable Anthelmintic Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Veterinary Pharmacies
5.1.6 Others
5.2 By Application - Global Injectable Anthelmintic Drugs Revenue & Forecasts
5.2.1 By Application - Global Injectable Anthelmintic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Injectable Anthelmintic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Injectable Anthelmintic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Injectable Anthelmintic Drugs Revenue & Forecasts
6.2.1 By Region - Global Injectable Anthelmintic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Injectable Anthelmintic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Injectable Anthelmintic Drugs Revenue, 2018-2030
6.3.2 US Injectable Anthelmintic Drugs Market Size, 2018-2030
6.3.3 Canada Injectable Anthelmintic Drugs Market Size, 2018-2030
6.3.4 Mexico Injectable Anthelmintic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Injectable Anthelmintic Drugs Revenue, 2018-2030
6.4.2 Germany Injectable Anthelmintic Drugs Market Size, 2018-2030
6.4.3 France Injectable Anthelmintic Drugs Market Size, 2018-2030
6.4.4 U.K. Injectable Anthelmintic Drugs Market Size, 2018-2030
6.4.5 Italy Injectable Anthelmintic Drugs Market Size, 2018-2030
6.4.6 Russia Injectable Anthelmintic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Injectable Anthelmintic Drugs Market Size, 2018-2030
6.4.8 Benelux Injectable Anthelmintic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Injectable Anthelmintic Drugs Revenue, 2018-2030
6.5.2 China Injectable Anthelmintic Drugs Market Size, 2018-2030
6.5.3 Japan Injectable Anthelmintic Drugs Market Size, 2018-2030
6.5.4 South Korea Injectable Anthelmintic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Injectable Anthelmintic Drugs Market Size, 2018-2030
6.5.6 India Injectable Anthelmintic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Injectable Anthelmintic Drugs Revenue, 2018-2030
6.6.2 Brazil Injectable Anthelmintic Drugs Market Size, 2018-2030
6.6.3 Argentina Injectable Anthelmintic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Injectable Anthelmintic Drugs Revenue, 2018-2030
6.7.2 Turkey Injectable Anthelmintic Drugs Market Size, 2018-2030
6.7.3 Israel Injectable Anthelmintic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Injectable Anthelmintic Drugs Market Size, 2018-2030
6.7.5 UAE Injectable Anthelmintic Drugs Market Size, 2018-2030
7 Injectable Anthelmintic Drugs Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Injectable Anthelmintic Drugs Major Product Offerings
7.1.4 Novartis Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Cipla
7.2.1 Cipla Company Summary
7.2.2 Cipla Business Overview
7.2.3 Cipla Injectable Anthelmintic Drugs Major Product Offerings
7.2.4 Cipla Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.2.5 Cipla Key News & Latest Developments
7.3 Sun Pharmaceutical Industries
7.3.1 Sun Pharmaceutical Industries Company Summary
7.3.2 Sun Pharmaceutical Industries Business Overview
7.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Major Product Offerings
7.3.4 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.3.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.4 Amneal Pharmaceuticals
7.4.1 Amneal Pharmaceuticals Company Summary
7.4.2 Amneal Pharmaceuticals Business Overview
7.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Major Product Offerings
7.4.4 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.4.5 Amneal Pharmaceuticals Key News & Latest Developments
7.5 Zoetis
7.5.1 Zoetis Company Summary
7.5.2 Zoetis Business Overview
7.5.3 Zoetis Injectable Anthelmintic Drugs Major Product Offerings
7.5.4 Zoetis Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.5.5 Zoetis Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Injectable Anthelmintic Drugs Major Product Offerings
7.7.4 Bayer Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Injectable Anthelmintic Drugs Major Product Offerings
7.8.4 Merck Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Boehringer Ingelheim International
7.9.1 Boehringer Ingelheim International Company Summary
7.9.2 Boehringer Ingelheim International Business Overview
7.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Major Product Offerings
7.9.4 Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.9.5 Boehringer Ingelheim International Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Injectable Anthelmintic Drugs Market Opportunities & Trends in Global Market
Table 2. Injectable Anthelmintic Drugs Market Drivers in Global Market
Table 3. Injectable Anthelmintic Drugs Market Restraints in Global Market
Table 4. Key Players of Injectable Anthelmintic Drugs in Global Market
Table 5. Top Injectable Anthelmintic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Injectable Anthelmintic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Injectable Anthelmintic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Injectable Anthelmintic Drugs Product Type
Table 9. List of Global Tier 1 Injectable Anthelmintic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Injectable Anthelmintic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Injectable Anthelmintic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Injectable Anthelmintic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Injectable Anthelmintic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Injectable Anthelmintic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Injectable Anthelmintic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Injectable Anthelmintic Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Novartis Company Summary
Table 31. Novartis Injectable Anthelmintic Drugs Product Offerings
Table 32. Novartis Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Cipla Company Summary
Table 35. Cipla Injectable Anthelmintic Drugs Product Offerings
Table 36. Cipla Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Cipla Key News & Latest Developments
Table 38. Sun Pharmaceutical Industries Company Summary
Table 39. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product Offerings
Table 40. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Sun Pharmaceutical Industries Key News & Latest Developments
Table 42. Amneal Pharmaceuticals Company Summary
Table 43. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product Offerings
Table 44. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Amneal Pharmaceuticals Key News & Latest Developments
Table 46. Zoetis Company Summary
Table 47. Zoetis Injectable Anthelmintic Drugs Product Offerings
Table 48. Zoetis Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Zoetis Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Injectable Anthelmintic Drugs Product Offerings
Table 52. GlaxoSmithKline Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Injectable Anthelmintic Drugs Product Offerings
Table 56. Bayer Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Injectable Anthelmintic Drugs Product Offerings
Table 60. Merck Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Boehringer Ingelheim International Company Summary
Table 63. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product Offerings
Table 64. Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Boehringer Ingelheim International Key News & Latest Developments
List of Figures
Figure 1. Injectable Anthelmintic Drugs Segment by Type in 2022
Figure 2. Injectable Anthelmintic Drugs Segment by Application in 2022
Figure 3. Global Injectable Anthelmintic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Injectable Anthelmintic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Injectable Anthelmintic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2022
Figure 8. By Type - Global Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 16. US Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 28. China Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Injectable Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Injectable Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Novartis Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cipla Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Zoetis Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bayer Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Boehringer Ingelheim International Injectable Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
